incomplete and spontaneous abortions, induction of labor, augmentation of labor, and treatment of postpartum hemorrhage (PPH). 4 Misoprostol has advantages in being cheap and stable at room temperature and widely available also in most resource-poor settings. Misoprostol is included in the World Health Organization (WHO) essential medicine list on several indications including labor induction. 4 Misoprostol has been widely studied in a variety of dosages and routes of administration as an alternative to oxytocin. Misoprostol offers the advantage of promoting both cervical ripening and myometrial contractility. 5 Success of induction of labor depends on cervical ripening. Various methods are available for induction of labor but the search for the ideal agent, timing, and dosage interval to convert an unfavourable cervix to one receptive to delivery is an ongoing process. Attention has been focused on prostaglandins as effective pharmacological adjuncts to induction.
Sublingual and vaginal routes have prolonged activity and possess the greatest bioavailability. 6 Benefits of the sublingual route might include less frequent need for vaginal examinations, greater freedom of position in the labor bed, and ease of administration. 7 The aim of this study is to compare the previously used vaginal administration of Misoprostol with sublingual administration for labor induction regarding induction delivery interval, maternal and neonatal outcome. Progress of labour was monitored by maintaining partograph along with clinical monitoring of Bishops score every time before giving Misoprostol, foetal heart rate and uterine contractions. Any deviation from normal was dealt with, as and when required accordingly. All cases were closely watched. Important outcomes regarding induction to delivery interval, mode of delivery (vaginal, instrumental, caesarean), successful induction (4-5 cm of cervical dilatation with effective uterine contractions within 4 hours of last dose of Misoprostol), foetal heart rate variation, indication for caesarean section, number of Misoprostol doses, dysfunctional uterine action (hyper stimulation and tachysystole) and Misoprostol related side effects (nausea, vomiting, fever, shivering, headache, diarrhoea) were noted. Neonatal outcome in terms Apgar score at one and five minutes, passage of meconium, cause of NICU admission and neonatal mortality, if any. Tachysystole was defined as six or more uterine contractions in 10 minutes. Uterine hyper stimulation was defined as tachysystole associated with abnormal foetal heart pattern.
METHODS

Statistical analysis
Statistical analysis of the data is carried out using statistical packages for SPSS 16.0 for Windows (SPSS Inc., Chicago, IL, USA). Continuous and categorical variables are expressed as mean±SD and percentages, respectively. Z test for proportion and Chi -square test is applied to compare between two categorical data. Students t-test is applied to compare between the two continuous data. p < 0.5 was considered statistically significant.
RESULTS
200 pregnant women admitted in the department for induction of labour were randomly divided into 2 groups of 100 cases in each group. In 100 cases 25 mcg Misoprostol was given sublingually labelled as Group A and other 100 cases were given 25 mcg Misoprostol per vaginally labelled as Group B. These 2 groups were compared and following results were obtained. There was no significant difference of demographic profiles and indications of induction of the cases of both the groups (Table 1 and Table 2 ). (Table 4) . Table 5 showed, there was no significant difference of maternal adverse effects of Misoprostol induction whether it was administered by sublingual route or vaginal route (p value 0.078) yet we found more cases of fever and vomiting in Group A while hyperstimulation and tachysystole was seen in cases of Group B. We did not find any significant difference in both the groups regarding neonatal outcomes ( 
Neonatal adverse effects Group A Group B p value
Apgar score at 1 min 6.84±1. 16 
DISCUSSION
The search for the ideal agent, timing, and dosage interval to convert an unfavorable cervix to one receptive to delivery is an ongoing process. Attention has been focused on Misoprostol, a synthetic analogue of prostaglandin E1, widely studied in a variety of dosages and routes of administration. Vaginal route of Misoprostol use is extensively studied but limited literature is available on sublingual route although it is more convenient for the patient and easy in administration. 7, 8 Even in our institute, there was only vaginal use till now. Therefore, this study was conducted to compare the safety, efficacy and tolerability of sublingual versus vaginal Misoprostol for induction of labor at term. In our study both the groups are similar in their demographic profile. There was no significant difference in parity too. [10] [11] [12] Our study is similar to other previous studies found no significant difference in the number of doses required for the induction by sublingual or vaginal route. 10, 13 On contrary significantly higher doses are needed for induction by sublingual Misoprostol in the study conducted by Ahmed B et al. 12 Similar to other studies conducted previously, most of the cases of sublingual group were delivered within 24 hours and statistically significant number of cases of sublingual group delivered within shorter interval i.e. 12 hours as compared to vaginal group (58% and 42%, p 0.02) possibly due to faster action of sublingual route. 14, 15 Although majority of cases of both the groups (86% and 62% respectively) were delivered vaginally but still statistically significant number of cases of sublingual group (86%) were delivered vaginally (p value < 0.001) while significant number of cases had undergone caesarean among the cases induced by vaginal Misoprostol (29% p value < 0.001). Sedigheh A et al, found maximum delivery in both the groups by vaginal route (84% and 90% respectively) but more caesarean delivery in the group of sublingual Misoprostol administration (14%) as compared to vaginal Misoprostol (10%) but this difference was not statistically significant. 10 The result of study of Ahmed B et al and Feitosa FEL et al, showed much higher rate of caesarean in sublingual group. 10, 12, 13 Similar to our study instrumental delivery was also higher in vaginal group of Ahmed B et al, study though it was statistically nonsignificant. 12 11, 18, 19 Both cases of hyper stimulation normal vaginally delivered after being treated for hyper stimulation. All cases were managed with left lateral position and oxygen inhalation and further administration of the drug was stopped. As well as there was no significant difference in adverse neonatal outcomes and NICU admissions of both the groups in aspect of Apgar score at 1 and 5 minutes and passage of meconium which was also similar to previous studies. 15, 18, 20 The reason of higher frequency of uterine hyperstimulation and tachysystole in vaginal group is its higher efficacy and bioavailability because of avoidance of first pass effect of GIT and hepatic enzymes as well as direct effect on cervix and uterus. 21, 22 Studies done previously had similar results regarding no significant difference in safety of mother as well as fetus by vaginal and sublingual administration of Misoprostol. 13, 14 However, the study of Caliskan E et al, showed significant number of women of sublingual group developed tachysystole (p = 0.005) than vaginal group with similar neonatal outcomes. 23
CONCLUSION
From above study we concluded that use of sublingual or vaginal Misoprostol are similar in favorable maternal and neonatal outcome but sublingual route is preferable in achieving more successful vaginal delivery within short period of induction with minimal failure of induction (Although it was inconclusive due to small sample size). Sublingual administration has an added advantage for the women, particularly to those who were wishing to avoid multiple vaginal administration. Sublingual Misoprostol is an effective alternative to vaginal Misoprostol in induction of labor. More studies and trails are needed to use sublingual Misoprostol in future for induction of labor.
